Burden of chronic obstructive pulmonary disease in China from 1990 to 2021: a population-based study
While the ASR of COPD in China has significantly improved, the absolute burden continues to escalate, with notable differences by age and sex. Future efforts should focus on enhancing preventive measures for major risk factors and implementing early screening for high-risk populations to promote early diagnosis and treatment strategies, thereby alleviating the disease burden.
Authors
- Xiuqin Zeng
- Xuefang Wang (ORCID: https://orcid.org/0000-0001-8104-4408)
- Jing Liu (ORCID: https://orcid.org/0000-0002-4778-766X)
- Juan Li (ORCID: https://orcid.org/0000-0002-5829-5142)
- Ruijun Cai
- Ling Zhang (ORCID: https://orcid.org/0009-0005-5935-5097)
Institutions
- Jiuquan Iron & Steel (China) (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-10-15
- DOI
- https://doi.org/10.3389/fmed.2025.1674952
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00